Published in Sci Rep on January 19, 2017
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Autonomic nerve development contributes to prostate cancer progression. Science (2013) 6.11
Denervation suppresses gastric tumorigenesis. Sci Transl Med (2014) 1.96
Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer (2011) 1.64
Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res (2003) 1.61
Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol (2008) 1.42
Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev (2010) 1.35
M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. Cancer Res (2007) 1.23
Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol (2009) 1.19
Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function. Life Sci (2012) 1.18
Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice. Carcinogenesis (2011) 1.16
ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. Invest Ophthalmol Vis Sci (2008) 1.08
The cholinergic system and cancer. Semin Cancer Biol (2007) 1.00
Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists. Med Res Rev (2009) 1.00
Reconciling neuronally and nonneuronally derived acetylcholine in the regulation of immune function. Ann N Y Acad Sci (2012) 0.95
Muscarinic receptor agonists and antagonists: effects on cancer. Handb Exp Pharmacol (2012) 0.94
Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression. Cancer Res (2015) 0.92
Evolution of gastric surgery techniques and outcomes. Chin J Cancer (2016) 0.89
Paradoxical regulation of ChAT and nNOS expression in animal models of Crohn's colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol (2013) 0.87
Muscarinic receptor M3 mediates cell proliferation induced by acetylcholine and contributes to apoptosis in gastric cancer. Tumour Biol (2015) 0.86
Muscarinic receptor signaling in colon cancer. Cancers (Basel) (2011) 0.86
Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells. Hepatobiliary Pancreat Dis Int (2012) 0.85
MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells. Oncotarget (2016) 0.84
High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer. Tumour Biol (2013) 0.82
Cholinergic receptors as target for cancer therapy in a systems medicine perspective. Curr Mol Med (2014) 0.81
Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models. Eur J Neurosci (2016) 0.80
Is acetylcholine an autocrine/paracrine growth factor via the nicotinic alpha7-receptor subtype in the human colon cancer cell line HT-29? Eur J Pharmacol (2009) 0.80
Cholinergic Targets in Lung Cancer. Curr Pharm Des (2016) 0.79
Muscarinic signaling in carcinoma cells. Life Sci (2003) 0.79
M1 is a major subtype of muscarinic acetylcholine receptors on mouse colonic epithelial cells. J Gastroenterol (2012) 0.79
Exercise leads to the re-emergence of the cholinergic/nestin neuronal phenotype within the medial septum/diagonal band and subsequent rescue of both hippocampal ACh efflux and spatial behavior. Exp Neurol (2016) 0.78
Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma. BMC Cancer (2015) 0.78
Muscarinic acetylcholine receptor M3 modulates odorant receptor activity via inhibition of β-arrestin-2 recruitment. Nat Commun (2015) 0.77
Selective activation of α7 nicotinic acetylcholine receptors augments hippocampal oscillations. Neuropharmacology (2016) 0.77
Contribution of the Cholinergic System to Verbal Memory Performance in Mild Cognitive Impairment. J Alzheimers Dis (2016) 0.77
Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer. Curr Pharm Des (2016) 0.76